Citigroup’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
Sell
-1,770,806
Closed -$31.9M 5274
2020
Q2
$31.9M Buy
1,770,806
+1,684,734
+1,957% +$30.3M 0.02% 358
2020
Q1
$614K Buy
86,072
+21,501
+33% +$153K ﹤0.01% 2152
2019
Q4
$1.54M Sell
64,571
-60,484
-48% -$1.44M ﹤0.01% 1874
2019
Q3
$3.35M Sell
125,055
-99,343
-44% -$2.66M ﹤0.01% 1274
2019
Q2
$6.09M Buy
224,398
+201,501
+880% +$5.47M ﹤0.01% 1036
2019
Q1
$794K Sell
22,897
-552,248
-96% -$19.2M ﹤0.01% 2151
2018
Q4
$11.2M Buy
575,145
+36,649
+7% +$715K 0.01% 653
2018
Q3
$14.3M Buy
538,496
+449,005
+502% +$12M 0.01% 570
2018
Q2
$3.38M Buy
89,491
+11,607
+15% +$438K ﹤0.01% 1201
2018
Q1
$2.54M Sell
77,884
-3,178
-4% -$104K ﹤0.01% 1323
2017
Q4
$3.95M Buy
81,062
+21,048
+35% +$1.02M ﹤0.01% 1096
2017
Q3
$3.24M Buy
60,014
+6,800
+13% +$367K ﹤0.01% 1188
2017
Q2
$2.99M Buy
53,214
+21,347
+67% +$1.2M ﹤0.01% 1223
2017
Q1
$1.25M Sell
31,867
-107,221
-77% -$4.2M ﹤0.01% 1756
2016
Q4
$3.12M Buy
139,088
+135,920
+4,290% +$3.05M ﹤0.01% 1438
2016
Q3
$72K Sell
3,168
-648
-17% -$14.7K ﹤0.01% 3556
2016
Q2
$90K Sell
3,816
-71,147
-95% -$1.68M ﹤0.01% 3386
2016
Q1
$1.53M Sell
74,963
-730,473
-91% -$14.9M ﹤0.01% 1680
2015
Q4
$41.4M Buy
805,436
+204,715
+34% +$10.5M 0.04% 208
2015
Q3
$25.6M Buy
600,721
+592,160
+6,917% +$25.2M 0.02% 295
2015
Q2
$389K Sell
8,561
-3,350
-28% -$152K ﹤0.01% 2331
2015
Q1
$452K Sell
11,911
-5,589
-32% -$212K ﹤0.01% 2362
2014
Q4
$496K Buy
17,500
+16,216
+1,263% +$460K ﹤0.01% 2457
2014
Q3
$32K Sell
1,284
-1,489
-54% -$37.1K ﹤0.01% 3973
2014
Q2
$81K Sell
2,773
-1,982
-42% -$57.9K ﹤0.01% 3232
2014
Q1
$124K Sell
4,755
-1,794
-27% -$46.8K ﹤0.01% 3301
2013
Q4
$168K Buy
6,549
+6,534
+43,560% +$168K ﹤0.01% 3286
2013
Q3
$0 Sell
15
-4,497
-100% ﹤0.01% 5359
2013
Q2
$111K Buy
+4,512
New +$111K ﹤0.01% 3197